VG2D Pharma was on the front page of the regional magazine Grand Est

January 7, 2025

Share This Post

The VG2D Pharma team shared their ambitious vision for health equity with Grand Est, highlighting how the company plans to turn their slogan, “Innovation with Broader Reach,” into a tangible reality.

More To Explore

News

VG2D Pharma was at InnoRem, where Prof. Gérard and Dr. Velard presented the latest updates on our R&D roadmap.

InnoRem : The InnoRem hub, led by the University of Reims, aims to foster collaborations between innovative companies and research laboratories. The Innovation Festival, organized by Innovact on June 20

7 January 2025

News

VG2D Pharma and SATT signed an out licencing agreement

Following an outlicensing agreement with SATT Nord, a public entity managing intellectual property for the University of Reims Champagne-Ardenne (URCA), VG2D now holds full rights to exploit the molecule. The

7 January 2025

VG2D Pharma was on the front page of the regional magazine Grand Est

Share This Post

More To Explore

VG2D Pharma was at InnoRem, where Prof. Gérard and Dr. Velard presented the latest updates on our R&D roadmap.

VG2D Pharma and SATT signed an out licencing agreement

Interested in learning more about VG2D Pharma and its solution ?

Request our investors’ deck or express interest in joining our team or collaborating with us.

VG2D Pharma was on the front page of the regional magazine Grand Est

Share This Post

More To Explore

VG2D Pharma was at InnoRem, where Prof. Gérard and Dr. Velard presented the latest updates on our R&D roadmap.

VG2D Pharma and SATT signed an out licencing agreement

Interested in learning more about VG2D Pharma and its solution ?

Request our investors’ deck or express interest in joining our team or collaborating with us.

Start A Conversation

Leave Us A Message